These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 25426552

  • 1. Inhibition of glioblastoma malignancy by Lgl1.
    Gont A, Hanson JE, Lavictoire SJ, Daneshmand M, Nicholas G, Woulfe J, Kassam A, Da Silva VF, Lorimer IA.
    Oncotarget; 2014 Nov 30; 5(22):11541-51. PubMed ID: 25426552
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Identification of Rac guanine nucleotide exchange factors promoting Lgl1 phosphorylation in glioblastoma.
    Lavictoire SJ, Jomaa D, Gont A, Jardine K, Cook DP, Lorimer IAJ.
    J Biol Chem; 2021 Nov 30; 297(5):101172. PubMed ID: 34624316
    [Abstract] [Full Text] [Related]

  • 4. Regulation of glioblastoma cell invasion by PKC iota and RhoB.
    Baldwin RM, Parolin DA, Lorimer IA.
    Oncogene; 2008 Jun 05; 27(25):3587-95. PubMed ID: 18212741
    [Abstract] [Full Text] [Related]

  • 5. Reduced expression of Hugl-1, the human homologue of Drosophila tumour suppressor gene lgl, contributes to progression of colorectal cancer.
    Schimanski CC, Schmitz G, Kashyap A, Bosserhoff AK, Bataille F, Schäfer SC, Lehr HA, Berger MR, Galle PR, Strand S, Strand D.
    Oncogene; 2005 Apr 28; 24(19):3100-9. PubMed ID: 15735678
    [Abstract] [Full Text] [Related]

  • 6. The tumor suppressor Lgl1 forms discrete complexes with NMII-A and Par6α-aPKCζ that are affected by Lgl1 phosphorylation.
    Dahan I, Petrov D, Cohen-Kfir E, Ravid S.
    J Cell Sci; 2014 Jan 15; 127(Pt 2):295-304. PubMed ID: 24213535
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. TrkB-containing exosomes promote the transfer of glioblastoma aggressiveness to YKL-40-inactivated glioblastoma cells.
    Pinet S, Bessette B, Vedrenne N, Lacroix A, Richard L, Jauberteau MO, Battu S, Lalloué F.
    Oncotarget; 2016 Aug 02; 7(31):50349-50364. PubMed ID: 27385098
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Expression of Hugl-1 is strongly reduced in malignant melanoma.
    Kuphal S, Wallner S, Schimanski CC, Bataille F, Hofer P, Strand S, Strand D, Bosserhoff AK.
    Oncogene; 2006 Jan 05; 25(1):103-10. PubMed ID: 16170365
    [Abstract] [Full Text] [Related]

  • 14. Expression of the constitutively activated RelA/NF-kappaB in human astrocytic tumors and the in vitro implication in the regulation of urokinase-type plasminogen activator, migration, and invasion.
    Tsunoda K, Kitange G, Anda T, Shabani HK, Kaminogo M, Shibata S, Nagata I.
    Brain Tumor Pathol; 2005 Jan 05; 22(2):79-87. PubMed ID: 18095109
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis.
    Lakka SS, Gondi CS, Yanamandra N, Olivero WC, Dinh DH, Gujrati M, Rao JS.
    Oncogene; 2004 Jun 10; 23(27):4681-9. PubMed ID: 15122332
    [Abstract] [Full Text] [Related]

  • 17. Tumoral RANKL activates astrocytes that promote glioma cell invasion through cytokine signaling.
    Kim JK, Jin X, Sohn YW, Jin X, Jeon HY, Kim EJ, Ham SW, Jeon HM, Chang SY, Oh SY, Yin J, Kim SH, Park JB, Nakano I, Kim H.
    Cancer Lett; 2014 Oct 28; 353(2):194-200. PubMed ID: 25079688
    [Abstract] [Full Text] [Related]

  • 18. The in vitro influences of neurotensin on the motility characteristics of human U373 glioblastoma cells.
    Servotte S, Camby I, Debeir O, Deroanne C, Lambert CA, Lapière CM, Kiss R, Nusgens B, Decaestecker C.
    Neuropathol Appl Neurobiol; 2006 Dec 28; 32(6):575-84. PubMed ID: 17083472
    [Abstract] [Full Text] [Related]

  • 19. Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria.
    Günther HS, Schmidt NO, Phillips HS, Kemming D, Kharbanda S, Soriano R, Modrusan Z, Meissner H, Westphal M, Lamszus K.
    Oncogene; 2008 May 01; 27(20):2897-909. PubMed ID: 18037961
    [Abstract] [Full Text] [Related]

  • 20. Costimulatory protein 4IgB7H3 drives the malignant phenotype of glioblastoma by mediating immune escape and invasiveness.
    Lemke D, Pfenning PN, Sahm F, Klein AC, Kempf T, Warnken U, Schnölzer M, Tudoran R, Weller M, Platten M, Wick W.
    Clin Cancer Res; 2012 Jan 01; 18(1):105-17. PubMed ID: 22080438
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.